Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

DBV Technologies

DBV Technologies reported $23.36M in Operating Expenses for its fiscal quarter ending in March of 2023.

Operating Expenses Change
Acadia Pharmaceuticals ACAD:US USD 172.05M 10.51M
Alnylam Pharmaceuticals ALNY:US USD 469.1M 54.55M
BioCryst Pharmaceuticals BCRX:US USD 97.19M 28.66M
BioMarin Pharmaceutical BMRN:US USD 537.07M 24.97M
Esperion Therapeutics ESPR:US USD 72.93M 11.6M
Galectin Therapeutics GALT:US USD 10.34M 291K
Halozyme Therapeutics HALO:US USD 108.34M 1.35M
Incyte Corp INCY:US USD 783.9M 72.7M
Insmed INSM:US USD 213.37M 2.6M
Intercept Pharmaceuticals ICPT:US USD 99.59M 4.35M
Ionis Pharmaceuticals IONS:US USD 244.67M 115.24M
Neurocrine Biosciences NBIX:US USD 534.6M 226M
PTC Therapeutics PTCT:US USD 338M 29.76M
Sarepta Therapeutics SRPT:US USD 778.92M 411.08M
Ultragenyx Pharmaceutical RARE:US USD 254.6M 5.62M
United Therapeutics UTHR:US USD 222.5M 93.4M